Glucose
Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal
2022
BENTONVILLE AR -- October 24, 2022 -- InvestorsHub NewsWire --
Glucose Health, Inc. (OTC:
GLUC) ("Company") is pleased to highlight selected financial
information from its third Quarterly Report of Fiscal 2022, for the
period ended September 30, 2022, posted today at OTCMarkets.com.
-
Q3 2022 Revenue of
$340,681 vs. $234,930 for Q3 2021 = a 45% increase.
-
Q3 2022 Gross Profit of
$153,789 vs. $62,032 for Q3 2021 = a 148% increase.
-
Q3 2022 Net Income
of $8,091 vs. Q3
2021 Net Loss
of $133,160.
The
Company additionally advises shareholders and interested investors
that a progress report regarding its planned up-listing to the
NASDAQ Capital Market® stock exchange is expected to be issued by
press release, the week of October 31, 2022.
About Glucose Health, Inc. (OTC:
GLUC)
By specializing in producing healthy and delicious beverages
nutritionally appropriate1 for
the nation's 100+ million2 pre
and Type-2 diabetics, and additionally, with its planned launch of
a new healthy and delicious soluble fiber infused "ready-to-drink"
beverage, formulated to meet the nutritional needs of the 95% of
Americans who are considered fiber deficient3,
Glucose Health, Inc. is uniquely positioned among all micro-cap
beverage companies in America. Glucose Health, Inc. is a publicly
traded company with the ticker symbol OTC: GLUC.
For more GLUC news visit www.glucosehealthinc.com
Like us on Facebook at www.facebook.com/glucodown
1 For
citations visit www.glucodown.com/clinical-data
2 National
Diabetes Statistics Review, 2020;
Centers for Disease Control and Prevention, Department of Health
and Human Services
3
Closing America's Fiber Intake Gap.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124841
Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827
This news release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and while Glucose
Health, Inc. is not subject to the 1934 Securities and Exchange
Act, contains forward-looking statements within the meaning Section
21E of the Securities and Exchange Act of 1934, as amended.
Statements that are not a description of historical facts
constitute forward-looking statements and may often, but not
always, be identified by the use of such words as "expects,"
"anticipates," "intends," "estimates," "plans," "potential,
"possible," "probable, "believes," "seeks," "may, "will, "should,"
"could" or the negative of such terms or other similar expressions.
Actual results may differ materially from those set forth in this
release due to the risks and uncertainties inherent in the
Company's business. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date hereof. All forward-looking statements are qualified in
their entirety by this cautionary statement and the Company
undertakes no obligation to revise or update this release to
reflect events or circumstances after the date hereof.